Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 23.55 | 20.07 |
| PEG Ratio (TTM) | 0.25 | -10.00 |
| P/S Ratio (TTM) | 1.58 | 2.87 |
| P/B Ratio (TTM) | 1.82 | 7.46 |
| P/FCF Ratio (TTM) | 15.38 | 29.66 |
| Price to 5YR AVG Earnings Ratio | 38.17 | 12.70 |
| Price to 5YR AVG FCF Ratio | 38.95 | 19.15 |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 7.74% | 7.87% |
| ROE (TTM) | 14.00% | 45.73% |
| Net Profit Margin (TTM) | 6.68% | 12.76% |
| ROIC 5YR AVG | 14.15% | 18.77% |
Growth (82%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 362,499.30% | 32.43% | 17.20% |
| Revenue | -0.64% | 8.65% | 9.22% |
| Net Income | 348,499.22% | 31.17% | 15.79% |
| Cash Flow | 123.85% | 8.24% | 82.71% |
Health (74%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.35 | 1.60 |
| Quick Ratio (TTM) | 1.55 | 1.18 |
| D/E Ratio (TTM) | 0.04 | 1.81 |
| Interest Coverage (TTM) | 14.17 | 3.47 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 3.91 | 3.51 |
| LTL to 5YR AVG FCF | 7.74 | 4.00 |
| Shares Outstanding Growth 5YR AVG | -1.23% | -1.06% |